Research groups
Parvinder Aley
Operations Manager
Parv joined the Oxford Vaccine Group in May 2016. She has a PhD in Cellular Physiology from the University of Leeds. Subsequently she moved to Oxford where she has worked at the University for the past 10 years, initially as a researcher and more recently as a Contracts Specialist. As Operational Manager, she is responsible for the strategic management of the group with the aim to facilitate research on the development and implementation of vaccines.
Recent publications
-
Nicotinic acid adenine dinucleotide phosphate (NAADP) is a second messenger in muscarinic receptor-induced contraction of guinea pig trachea.
Journal article
Aley PK. et al, (2013), J Biol Chem, 288, 10986 - 10993
-
A safe lithium mimetic for bipolar disorder.
Journal article
Singh N. et al, (2013), Nat Commun, 4
-
β-Adrenergic receptor signaling increases NAADP and cADPR levels in the heart.
Journal article
Lewis AM. et al, (2012), Biochem Biophys Res Commun, 427, 326 - 329
-
ß-Adrenergic receptor signaling increases NAADP and cADPR levels in the heart
Journal article
Lewis AM. et al, (2012), Biochemical and Biophysical Research Communications, 427, 326 - 329
-
Nicotinic acid adenine dinucleotide phosphate regulates skeletal muscle differentiation via action at two-pore channels (vol 107, pg 19927, 2010)
Journal article
Aley PK. et al, (2011), PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 108, 5139 - 5139